Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,070 | 1,359 | 62.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,434 | 7 | 34.1% |
| Travel and Lodging | $924.96 | 3 | 3.0% |
| Education | $171.74 | 15 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $13,001 | 99 | $0 (2024) |
| Lilly USA, LLC | $1,841 | 188 | $0 (2024) |
| Novo Nordisk Inc | $1,671 | 118 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,647 | 103 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,337 | 118 | $0 (2024) |
| ABBVIE INC. | $1,126 | 67 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $683.36 | 54 | $0 (2024) |
| PFIZER INC. | $638.70 | 50 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $594.86 | 53 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $531.45 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,371 | 137 | AstraZeneca Pharmaceuticals LP ($288.26) |
| 2023 | $2,094 | 126 | Lilly USA, LLC ($291.55) |
| 2022 | $2,646 | 178 | Lilly USA, LLC ($289.68) |
| 2021 | $2,442 | 171 | AbbVie Inc. ($405.47) |
| 2020 | $1,601 | 124 | Lilly USA, LLC ($241.93) |
| 2019 | $1,894 | 149 | Novo Nordisk Inc ($293.36) |
| 2018 | $2,620 | 214 | AstraZeneca Pharmaceuticals LP ($297.73) |
| 2017 | $14,932 | 285 | Janssen Pharmaceuticals, Inc ($12,240) |
All Payment Transactions
1,384 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: PAIN | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, FLULAVAL QUADRIVALENT | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: VACCINES | ||||||
| 12/11/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Endocrinology | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Biological | ||||||
| 11/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: UROLOGY | ||||||
| 11/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/20/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/20/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $3.49 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: PAIN | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Endocrinology | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,268 | 3,067 | $320,356 | $121,841 |
| 2022 | 30 | 2,511 | 3,455 | $345,271 | $130,697 |
| 2021 | 31 | 2,739 | 3,783 | $362,783 | $142,068 |
| 2020 | 30 | 2,826 | 3,967 | $306,341 | $102,352 |
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 265 | 464 | $85,840 | $36,469 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 191 | 191 | $37,245 | $24,156 | 64.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 123 | 136 | $47,892 | $17,548 | 36.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 191 | 216 | $27,303 | $12,974 | 47.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 91 | $11,375 | $5,161 | 45.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 199 | 231 | $18,220 | $3,802 | 20.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 237 | 348 | $31,609 | $3,599 | 11.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 53 | 53 | $3,180 | $3,116 | 98.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 242 | 367 | $12,111 | $2,785 | 23.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 103 | 247 | $13,585 | $2,351 | 17.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 154 | 170 | $10,200 | $2,194 | 21.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 63 | $2,520 | $1,859 | 73.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 101 | 101 | $4,040 | $1,818 | 45.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 22 | 22 | $2,750 | $1,264 | 46.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 92 | 114 | $1,140 | $957.60 | 84.0% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 14 | 20 | $1,760 | $505.80 | 28.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 37 | 48 | $2,688 | $416.56 | 15.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 30 | 36 | $2,808 | $298.44 | 10.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 42 | $1,890 | $290.37 | 15.4% |
| 90471 | Administration of vaccine | Office | 2023 | 13 | 14 | $630.00 | $172.48 | 27.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 23 | 25 | $550.00 | $75.54 | 13.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 68 | $1,020 | $27.42 | 2.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 286 | 534 | $98,790 | $41,969 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 173 | 173 | $33,735 | $22,318 | 66.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 68 | 72 | $25,200 | $10,786 | 42.8% |
About Dr. Michael Mcpherson, MD
Dr. Michael Mcpherson, MD is a Internal Medicine healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053322016.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Mcpherson, MD has received a total of $30,601 in payments from pharmaceutical and medical device companies, with $2,371 received in 2024. These payments were reported across 1,384 transactions from 68 companies. The most common payment nature is "Food and Beverage" ($19,070).
As a Medicare-enrolled provider, Mcpherson has provided services to 10,344 Medicare beneficiaries, totaling 14,272 services with total Medicare billing of $496,958. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lubbock, TX
- Active Since 08/11/2006
- Last Updated 03/22/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053322016
Products in Payments
- XARELTO (Drug) $12,946
- TRELEGY ELLIPTA (Drug) $940.73
- FARXIGA (Drug) $772.64
- TRULICITY (Drug) $727.31
- Ozempic (Drug) $670.81
- VRAYLAR (Drug) $627.95
- ENTRESTO (Drug) $614.04
- JARDIANCE (Drug) $534.70
- XIFAXAN (Drug) $532.00
- INJECTAFER (Drug) $445.42
- MOUNJARO (Drug) $429.59
- Trintellix (Drug) $391.46
- REXULTI (Drug) $365.51
- SYMBICORT (Drug) $357.51
- ELIQUIS (Drug) $328.94
- Victoza (Drug) $326.86
- UBRELVY (Drug) $295.96
- Kerendia (Drug) $279.18
- TRINTELLIX (Drug) $271.30
- Rybelsus (Drug) $253.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lubbock
Dr. Mohammad Ansari, M.d, M.D
Internal Medicine — Payments: $257,147
Mohammed Bakdash, M.d, M.D
Internal Medicine — Payments: $241,102
Sharma Prabhakar, M.d, M.D
Internal Medicine — Payments: $47,803
Dr. Joseph Wolcott, M.d, M.D
Internal Medicine — Payments: $37,371
Jose Suarez, Md, MD
Internal Medicine — Payments: $36,074
Scott Shurmur, Md, MD
Internal Medicine — Payments: $21,697